Global Demand for Rapid Animal Disease Detection

The Veterinary Infectious Disease Diagnostics Market, valued at USD 2.3 billion in 2025, is projected to reach USD 6.0 billion by 2035, registering a compound annual growth rate (CAGR) of 10.1% during the forecast period. This growth is being driven by rising pet ownership, increased awareness of animal health, and advancements in diagnostic technologies for both companion and livestock animals.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14276

The market is evolving rapidly, as stakeholders focus on early detection, precision medicine, and integrated laboratory services, which improve healthcare outcomes for animals while mitigating the risk of zoonotic disease transmission.

Market Drivers and Opportunities

Several factors are propelling the growth of the veterinary infectious disease diagnostics market:

• Rising Prevalence of Zoonotic Diseases: Diseases that can transfer from animals to humans are becoming a major public health concern, highlighting the need for timely diagnosis.
• Growth in Pet Ownership: Companion animals are increasingly seen as family members, fueling demand for diagnostic services that ensure their well-being.
• Technological Advancements: Innovations in immunodiagnostics and molecular diagnostics are enabling faster, more accurate detection of infectious diseases.
• Preventive Animal Healthcare: Rising expenditure on preventive care, vaccination, and routine diagnostics supports market expansion.
• Regulatory Emphasis on Biosecurity: Policies that promote livestock health management and veterinary lab standards are driving adoption of advanced diagnostic solutions.

Segmental Insights

Immunodiagnostics Technology Segment The immunodiagnostics segment dominates the technology category, accounting for 47.6% of market revenue in 2025. Its high accuracy, rapid pathogen detection, cost-effectiveness, and ease of use make it the preferred choice in veterinary settings. The technology is widely adopted for both companion and food-producing animals, and ongoing improvements in assay sensitivity and automation further strengthen its position.

Companion Animal Segment Companion animals account for 55.3% of market revenue under the animal type segment. This leadership reflects growing pet humanization trends, higher veterinary healthcare expenditure, and strong demand for routine diagnostics. With increasing insurance coverage and rising awareness among pet owners, companion animals are driving significant growth in the market.

Reference Laboratories End-User Segment Reference laboratories dominate the end-user category, representing 42.8% of revenue. Their capacity for high-throughput, precise testing and standardized protocols makes them the backbone of veterinary diagnostics. Investments in automation, molecular platforms, and global diagnostic networks further reinforce their market leadership.

Historical Context and Market Dynamics

The market has witnessed dramatic growth in recent years, with a CAGR of 11.9% from 2020 to 2025, primarily fueled by rapid pet adoption across developed and emerging economies, including the USA, France, China, Germany, and India. The global concern for zoonotic disease transmission, as highlighted by the CDC, further underscores the importance of veterinary infectious disease diagnostics.

Emerging economies are showing substantial growth potential due to increasing pet adoption, government support, and expanding farm animal populations. The proliferation of veterinary hospitals, clinics, and diagnostic laboratories is enhancing market accessibility and supporting steady growth.

Key Drivers of Veterinary Diagnostics Adoption:

• Pet Ownership and Well-Being: In North America, 68% of households own pets, emphasizing the importance of routine diagnostics.
• Preventive Healthcare Practices: Pet insurance coverage and veterinary wellness programs drive diagnostic service utilization.
• Expansion of Veterinary Infrastructure: Growth in laboratories, clinics, and veterinary professionals supports market expansion.

Market Restraints

Challenges such as high veterinary treatment costs, limited availability of advanced diagnostic laboratories in low-income regions, and lack of comprehensive pet insurance policies may restrain growth. However, innovation in diagnostic technologies and increasing awareness are mitigating these barriers.

Regional Insights

• United States: The market is expected to reach USD 1.7 billion by 2035, with a CAGR of 9.8%. Increased veterinary healthcare expenditure, animal health programs, and diagnostic innovation drive growth.
• United Kingdom: Expected market value of USD 206.2 million by 2035, with a CAGR of 9.1%. R&D reinvestment and advanced ELISA and RT-PCR technologies support growth.
• Japan: Projected market size of USD 351.6 million, focusing on bacterial and parasitic infections, including zoonoses, with innovations in biosensor diagnostics.
• Australia: Market value of USD 174.1 million, with emphasis on natural plant-derived veterinary medicines and 3D-printed supportive care solutions for pets.

Technological Innovation and New Market Entrants

Start-ups and emerging companies are contributing significantly to market evolution:

• Biotech Laboratories: Offers rapid assay diagnostic kits for infectious diseases, including Lyme disease, ehrlichiosis, and leptospirosis.
• Trecento Diagnostics: Provides non-invasive molecular tests for companion animals using urine-based DNA extraction techniques.
• Biogal and CisGEN: Deliver AI-enabled diagnostic solutions, patented feed supplements, and point-of-care testing kits for pets and livestock.

Established players and start-ups alike are leveraging AI, molecular diagnostics, and biosensor technologies to offer more accurate, faster, and cost-effective veterinary diagnostic solutions.

Browse the Complete Report: https://www.futuremarketinsights.com/reports/veterinary-infectious-disease-diagnostics-market